Biophysical and functional characterization of N-terminal domain of Human Interferon Regulatory Factor 6.
Biolayer Interferometry
Circular dichroism
DNA-binding domain
EMSA
Intrinsic fluorescence
Purification
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
02 Mar 2024
02 Mar 2024
Historique:
received:
25
09
2023
accepted:
02
01
2024
medline:
2
3
2024
pubmed:
2
3
2024
entrez:
1
3
2024
Statut:
epublish
Résumé
Interferon regulatory factor 6 (IRF6) has a key function in palate fusion during palatogenesis during embryonic development, and mutations in IRF6 cause orofacial clefting disorders. The in silico analysis of IRF6 is done to obtain leads for the domain boundaries and subsequently the sub-cloning of the N-terminal domain of IRF6 into the pGEX-2TK expression vector and successfully optimized the overexpression and purification of recombinant glutathione S-transferase-fused NTD-IRF6 protein under native conditions. After cleavage of the GST tag, NTD-IRF6 was subjected to protein folding studies employing Circular Dichroism and Intrinsic fluorescence spectroscopy at variable pH, temperature, and denaturant. CD studies showed predominantly alpha-helical content and the highest stability of NTD-IRF6 at pH 9.0. A comparison of native and renatured protein depicts loss in the secondary structural content. Intrinsic fluorescence and quenching studies have identified that tryptophan residues are majorly present in the buried areas of the protein and a small fraction was on or near the protein surface. Upon the protein unfolding with a higher concentration of denaturant urea, the peak of fluorescence intensity decreased and red shifted, confirming that tryptophan residues are majorly present in a more polar environment. While regulating IFN NTD-IRF6 consists of a mix of α-helix and β-sheets that show temperature-dependent cooperative unfolding between 40 °C and 55 °C. Urea-induced unfolding shows moderate tolerance to urea as the mid-transition concentration of urea (Cm) is 3.2 M. The tryptophan residues are majorly buried as depicted by fluorescence quenching studies. NTD-IRF6 has a specific and high affinity toward the promoter region of VRE-IFN
Sections du résumé
BACKGROUND
BACKGROUND
Interferon regulatory factor 6 (IRF6) has a key function in palate fusion during palatogenesis during embryonic development, and mutations in IRF6 cause orofacial clefting disorders.
METHODS AND RESULTS
RESULTS
The in silico analysis of IRF6 is done to obtain leads for the domain boundaries and subsequently the sub-cloning of the N-terminal domain of IRF6 into the pGEX-2TK expression vector and successfully optimized the overexpression and purification of recombinant glutathione S-transferase-fused NTD-IRF6 protein under native conditions. After cleavage of the GST tag, NTD-IRF6 was subjected to protein folding studies employing Circular Dichroism and Intrinsic fluorescence spectroscopy at variable pH, temperature, and denaturant. CD studies showed predominantly alpha-helical content and the highest stability of NTD-IRF6 at pH 9.0. A comparison of native and renatured protein depicts loss in the secondary structural content. Intrinsic fluorescence and quenching studies have identified that tryptophan residues are majorly present in the buried areas of the protein and a small fraction was on or near the protein surface. Upon the protein unfolding with a higher concentration of denaturant urea, the peak of fluorescence intensity decreased and red shifted, confirming that tryptophan residues are majorly present in a more polar environment. While regulating IFN
CONCLUSION
CONCLUSIONS
NTD-IRF6 consists of a mix of α-helix and β-sheets that show temperature-dependent cooperative unfolding between 40 °C and 55 °C. Urea-induced unfolding shows moderate tolerance to urea as the mid-transition concentration of urea (Cm) is 3.2 M. The tryptophan residues are majorly buried as depicted by fluorescence quenching studies. NTD-IRF6 has a specific and high affinity toward the promoter region of VRE-IFN
Identifiants
pubmed: 38429584
doi: 10.1007/s11033-024-09205-1
pii: 10.1007/s11033-024-09205-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
380Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Taniguchi T, Ogasawara K, Takaoka A, Tanaka N (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623–655
doi: 10.1146/annurev.immunol.19.1.623
pubmed: 11244049
Kousa YA, Schutte BC (2016) Toward an orofacial gene regulatory network. Dev Dyn 245(3):220–232
doi: 10.1002/dvdy.24341
pubmed: 26332872
Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S et al (2006) Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet 38(11):1335–1340
doi: 10.1038/ng1903
pubmed: 17041601
pmcid: 2082114
Oberbeck N, Pham VC, Webster JD, Reja R, Huang CS et al (2019) The RIPK4–IRF6 signalling axis safeguards epidermal differentiation and barrier function. Nature 574(7777):249–253
doi: 10.1038/s41586-019-1615-3
pubmed: 31578523
Rhea L, Canady FJ, Le M, Reeb T, Canady JW et al (2020) Interferon regulatory factor 6 is required for proper wound healing in vivo. Dev Dyn 249(4):509–522
doi: 10.1002/dvdy.134
pubmed: 31724286
Bailey CM, Hendrix MJ (2008) IRF6 in development and disease: a mediator of quiescence and differentiation. Cell Cycle 7(13):1925–1930
doi: 10.4161/cc.7.13.6221
pubmed: 18604160
Yan Y et al (2023) The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma. Cancers (Basel) 15(3):737
doi: 10.3390/cancers15030737
pubmed: 36765696
Botti E, Spallone G, Moretti F, Marinari B, Pinetti V et al (2011) Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci USA 108(33):13710–13715
doi: 10.1073/pnas.1110931108
pubmed: 21807998
pmcid: 3158164
Kwa MQ, Nguyen T, Huynh J, Ramnath D, De Nardo D et al (2014) Interferon regulatory factor 6 differentially regulates Toll-like receptor 2-dependent chemokine gene expression in epithelial cells. JBC 289(28):19758–19768
doi: 10.1074/jbc.M114.584540
Ramnath D, Tunny K, Hohenhaus DM, Pitts CM, Bergot AS et al (2015) TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes. Immunol Cell Bio 93(9):771–779
doi: 10.1038/icb.2015.77
Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS et al (2002) Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32(2):285–289
doi: 10.1038/ng985
pubmed: 12219090
pmcid: 3169431
Escalante CR, Yie J, Thanos D, Aggarwal AK (1998) Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391(6662):103–106
doi: 10.1038/34224
pubmed: 9422515
Escalante CR, Nistal-Villán E, Shen L, García-Sastre A, Aggarwal AK (2007) Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer. Mol Cell 26(5):703–716
doi: 10.1016/j.molcel.2007.04.022
pubmed: 17560375
Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y, Taniguchi T, Hakoshima T (1999) Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. Embo J 18(18):5028–5041
doi: 10.1093/emboj/18.18.5028
pubmed: 10487755
pmcid: 1171574
De Ioannes P, Escalante CR, Aggarwal AK (2011) Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA binding. Nucleic Acids Res 39(16):7300–7307
doi: 10.1093/nar/gkr325
pubmed: 21596780
pmcid: 3167601
Goodbourn S, Maniatis T (1988) Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proc Natl Acad Sci USA 85(5):1447–1451
doi: 10.1073/pnas.85.5.1447
pubmed: 3422743
pmcid: 279788
Thanos D, Maniatis T (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83(7):1091–1100
doi: 10.1016/0092-8674(95)90136-1
pubmed: 8548797
Little HJ, Rorick NK, Su LI, Baldock C, Malhotra S et al (2009) Missense mutations that cause Van der Woude syndrome and popliteal pterygium syndrome affect the DNA-binding and transcriptional activation functions of IRF6. Hum Mol Genet 18(3):535–545
doi: 10.1093/hmg/ddn381
pubmed: 19036739
Sinha BK, Meher P, Singh SK, Snehi S, Kashav T (2023) Homology modeling, cloning, overexpression, and GST-tagged protein purification of full-length and C-terminal domain of Human Interferon Regulatory Factor 6. Indian J Appl Pure Biol 38(2):908–919
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26(2):283–291
doi: 10.1107/S0021889892009944
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685
doi: 10.1038/227680a0
pubmed: 5432063
Apiyo DO (2017) Biolayer interferometry (Octet) for label-free biomolecular interaction sensing, In: Schasfoort R.B.M., editor. Handbook of Surface Plasmon Resonance, 2nd edn. Royal Society of Chemistry London, UK, pp. 356–3 97
Lakowicz JR (2006) Principles of fluorescence spectroscopy. Springer, New York
doi: 10.1007/978-0-387-46312-4
Francis DM, Page R (2010) Strategies to optimize protein expression in E. coli. Curr Protoc Protein Sci 61(1):5.24.1-5.24.29
doi: 10.1002/0471140864.ps0524s61
Ghisaidoobe AB, Chung SJ (2014) Intrinsic tryptophan fluorescence in the detection and analysis of proteins: a focus on Förster resonance energy transfer techniques. Int J Mol Sci 15(12):22518–22538
doi: 10.3390/ijms151222518
pubmed: 25490136
pmcid: 4284722
Eftink MR, Hagaman KA (1985) Fluorescence quenching of the buried tryptophan residue of cod parvalbumin. Biophys Chem 22(3):173–180
doi: 10.1016/0301-4622(85)80040-5
pubmed: 4052574
Albrecht C, Lakowicz JR (2008) Principles of fluorescence spectroscopy. Springer, New York
Barrows JK, Van Dyke MW (2022) Biolayer interferometry for DNA-protein interactions. PLoS ONE 17(2):e0263322
doi: 10.1371/journal.pone.0263322
pubmed: 35108320
pmcid: 8809612